Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Global Market

7.32USD
22 May 2018
Change (% chg)

$0.18 (+2.52%)
Prev Close
$7.14
Open
$7.14
Day's High
$7.32
Day's Low
$7.10
Volume
2,340
Avg. Vol
16,417
52-wk High
$96.25
52-wk Low
$6.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -3.339
FY 2017 Dec '17 0.00 -3.404
Sep '17 0.00 -6.989
Jun '17 0.00 -4.925
Mar '17 0.00 -4.981
FY 2016 Dec '16 0.00 -4.240
Sep '16 0.00 -4.845
Jun '16 0.00 -4.062
Mar '16 0.00 -5.877
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 11.42
Earnings (per share)
Quarter Ending Jun-18 2 -3.12 -3.00 -3.25 -4.50
Quarter Ending Sep-18 2 -3.38 -2.75 -4.00 -4.75
Year Ending Dec-18 2 -13.88 -12.75 -15.00 -19.25
Year Ending Dec-19 2 -11.50 -10.00 -13.00 -12.88
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 35.78 32.90
P/E High - Last 5 Yrs. -- 78.41 47.21
P/E Low - Last 5 Yrs. -- 22.76 24.78
Beta 2.44 0.88 0.79
Price to Sales (TTM) -- 29.71 8.29
Price to Book (MRQ) 1.36 4.75 4.33
Price to Tangible Book (MRQ) 1.36 5.02 5.85
Price to Cash Flow (TTM) -- 23.68 21.98
% Owned Institutions 9.76 28.40 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.71 1.65
Dividend Yield - 5 Year Avg -- 0.71 0.80
Dividend 5 Year Growth Rate -- 5.31 4.07
Payout Ratio(TTM) -- 13.17 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 10.97 4.91
Sales (TTM) vs TTM 1 Yr. Ago -- 9.05 12.76
Sales - 5 Yr. Growth Rate -- 5.53 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 32.97 72.96 35.43
EPS (TTM) vs TTM 1 Yr. Ago -2.92 -- --
EPS - 5 Yr. Growth Rate -- 15.76 8.55
Capital Spending - 5 Yr. Growth Rate -50.29 10.58 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.53
Current Ratio (MRQ) 3.20 2.24 3.60
LT Debt to Equity (MRQ) 3.40 31.78 12.91
Total Debt to Equity (MRQ) 8.92 41.23 15.97
Interest Coverage (TTM) -- 39.91 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.42 54.97
Gross Margin - 5 Yr. Avg. -- 55.61 52.78
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 13.66 15.93
Operating Margin (TTM) -- -19.41 0.12
Operating Margin - 5 Yr. Avg. -- 5.87 11.20
Pre-Tax Margin (TTM) -- -19.56 2.20
Pre-Tax Margin - 5 Yr. Avg. -- 4.97 11.41
Net Profit Margin (TTM) -- -22.16 -1.22
Net Profit Margin - 5 Yr. Avg. -- 2.47 7.70
Effective Tax Rate (TTM) -- 22.67 31.30
Effective Tax Rate - 5 Yr. Avg. -- 23.14 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 1,256,075 731,572,994
Net Income/Employee (TTM) -2,094,833 51,705 85,104,893
Receivable Turnover (TTM) -- 4.74 5.75
Inventory Turnover (TTM) -- 4.71 3.58
Asset Turnover (TTM) 0.00 0.73 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -119.02 -2.46 10.07
Return on Assets - 5 Yr. Avg. -133.37 5.09 11.12
Return on Investment (TTM) -147.75 8.07 12.74
Return on Investment - 5 Yr. Avg. -184.38 6.26 14.40
Return on Equity (TTM) -155.69 11.50 14.64
Return on Equity - 5 Yr. Avg. -205.00 7.44 15.76
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -7.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.76%
# of Holders: 50
Total Shares Held: 152,710
3 Mo. Net Change: -6,524
# New Positions: 5
# Closed Positions: 11
# Increased Positions: 12
# Reduced Positions: 20
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.